Thomas Lönngren speaks at FT Biotechnology and Biosimilars Forum

Thomas Lönngren, strategic advisor to NDA Group, was invited to speak at the FT’s Julphar Mena Biotechnology and Biosimilars Forum in Dubai 9th December 2013. Thomas held a keynote on the subject of ‘The Biosimilar Framework in EU’.

The Forum was chaired by Andrew Jack, Pharmaceuticals Correspondent, Financial Times, and brought together ‘industry experts, investors, policy makers and regulators from across the region and internationally to discuss the emerging opportunities and challenges for the development a vibrant biotechnology sector in the MENA’.

For further information on the event, please click here